China Sky One Medical, Inc. Out-Licenses Distribution of Prostate Drug

ChinaBio Today -- China Sky One Medical has signed up Shaanxi Buchang Group to distribute Naftopidil Dispersible tablets for China Sky One. China Sky One said its treatment for benign enlargement of the prostate gland is expected to generate sales of 100 million RMB ($14.6 million) over the next 5 years.

MORE ON THIS TOPIC